Caris Life Sciences (CAI) Cash & Current Investments (2024 - 2026)

Caris Life Sciences' Cash & Current Investments history runs 3 years deep, the most recent figure standing at $823.5 million for Q1 2026.

• In Q1 2026, Cash & Current Investments changed N/A year-over-year to $823.5 million; the TTM figure through Mar 2026 stood at $823.5 million (changed N/A YoY), while the FY2025 annual figure was $800.1 million, up 1095.35% from the prior year.
• Cash & Current Investments was $823.5 million for Q1 2026 at Caris Life Sciences, up from $800.1 million in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $823.5 million in Q1 2026 to a low of $66.9 million in Q4 2024.
• Historically, Cash & Current Investments has averaged $634.0 million across 3 years, with a median of $757.0 million in 2025.
• Biggest YoY gain for Cash & Current Investments was 1095.35% in 2025; the steepest drop was 1095.35% in 2025.
• A 3-year view of Cash & Current Investments shows it stood at $66.9 million in 2024, then jumped by 1095.35% to $800.1 million in 2025, then rose by 2.92% to $823.5 million in 2026.
• The last three Cash & Current Investments figures came in at $823.5 million (Q1 2026), $800.1 million (Q4 2025), and $757.0 million (Q3 2025), per Business Quant data.